Selected research
Industry Research
Mebendazole API Industry Research Report 2026
Market perspective
The global Mebendazole API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Mebendazole API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Mebendazole API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Mebendazole API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Mebendazole API include Shaanxi Hanjiang Pharmaceutical Group Co., Ltd, Jiangsu Quality Horizons Pharmtech Co., Ltd., Fengchen Group Co.,Ltd, Sudarshan Pharma Industries Limited, Solara Active Pharma Sciences, Optimus Drugs Pvt Ltd, K.A.Malle, Eurosoft Pharma Private Limited and Enomark Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Mebendazole API market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mebendazole API Market by Company
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd
Jiangsu Quality Horizons Pharmtech Co., Ltd.
Fengchen Group Co.,Ltd
Sudarshan Pharma Industries Limited
Solara Active Pharma Sciences
Optimus Drugs Pvt Ltd
K.A.Malle
Eurosoft Pharma Private Limited
Enomark Pharma
Dolphinpharma
Conscientia Industrial Co., Ltd
Cipla
Anant Pharmaceuticals
Mebendazole API Segment by Type
Purity≥99%
Purity<99%
Mebendazole API Segment by Application
Tablet
Solvent
Others
Mebendazole API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mebendazole API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mebendazole API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mebendazole API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Mebendazole API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Mebendazole API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Mebendazole API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity≥99%
- Purity<99%
Applications
- Tablet
- Solvent
- Others
Companies covered
- Shaanxi Hanjiang Pharmaceutical Group Co., Ltd
- Jiangsu Quality Horizons Pharmtech Co., Ltd.
- Fengchen Group Co.,Ltd
- Sudarshan Pharma Industries Limited
- Solara Active Pharma Sciences
- Optimus Drugs Pvt Ltd
- K.A.Malle
- Eurosoft Pharma Private Limited
- Enomark Pharma
- Dolphinpharma
- Conscientia Industrial Co., Ltd
- Cipla
- Anant Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Mebendazole API Market Size (2021-2032)
- 2.2.2 Global Mebendazole API Sales (2021-2032)
- 2.2.3 Global Mebendazole API Market Average Price (2021-2032)
- 2.3 Mebendazole API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity≥99%
- 2.3.3 Purity<99%
- 2.4 Mebendazole API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Tablet
- 2.4.3 Solvent
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Mebendazole API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Mebendazole API Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Mebendazole API Revenue of Manufacturers (2021-2026)
- 3.4 Global Mebendazole API Average Price by Manufacturers (2021-2026)
- 3.5 Global Mebendazole API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Mebendazole API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Mebendazole API, Product Type & Application
- 3.8 Global Manufacturers of Mebendazole API, Established Date
- 3.9 Global Mebendazole API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd
- 4.1.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Company Information
- 4.1.2 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Business Overview
- 4.1.3 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Mebendazole API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Mebendazole API Product Portfolio
- 4.1.5 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Recent Developments
- 4.2 Jiangsu Quality Horizons Pharmtech Co., Ltd.
- 4.2.1 Jiangsu Quality Horizons Pharmtech Co., Ltd. Company Information
- 4.2.2 Jiangsu Quality Horizons Pharmtech Co., Ltd. Business Overview
- 4.2.3 Jiangsu Quality Horizons Pharmtech Co., Ltd. Mebendazole API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Jiangsu Quality Horizons Pharmtech Co., Ltd. Mebendazole API Product Portfolio
- 4.2.5 Jiangsu Quality Horizons Pharmtech Co., Ltd. Recent Developments
- 4.3 Fengchen Group Co.,Ltd
- 4.3.1 Fengchen Group Co.,Ltd Company Information
- 4.3.2 Fengchen Group Co.,Ltd Business Overview
- 4.3.3 Fengchen Group Co.,Ltd Mebendazole API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fengchen Group Co.,Ltd Mebendazole API Product Portfolio
- 4.3.5 Fengchen Group Co.,Ltd Recent Developments
- 4.4 Sudarshan Pharma Industries Limited
- 4.4.1 Sudarshan Pharma Industries Limited Company Information
- 4.4.2 Sudarshan Pharma Industries Limited Business Overview
- 4.4.3 Sudarshan Pharma Industries Limited Mebendazole API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sudarshan Pharma Industries Limited Mebendazole API Product Portfolio
- 4.4.5 Sudarshan Pharma Industries Limited Recent Developments
- 4.5 Solara Active Pharma Sciences
- 4.5.1 Solara Active Pharma Sciences Company Information
- 4.5.2 Solara Active Pharma Sciences Business Overview
- 4.5.3 Solara Active Pharma Sciences Mebendazole API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Solara Active Pharma Sciences Mebendazole API Product Portfolio
- 4.5.5 Solara Active Pharma Sciences Recent Developments
- 4.6 Optimus Drugs Pvt Ltd
- 4.6.1 Optimus Drugs Pvt Ltd Company Information
- 4.6.2 Optimus Drugs Pvt Ltd Business Overview
- 4.6.3 Optimus Drugs Pvt Ltd Mebendazole API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Optimus Drugs Pvt Ltd Mebendazole API Product Portfolio
- 4.6.5 Optimus Drugs Pvt Ltd Recent Developments
- 4.7 K.A.Malle
- 4.7.1 K.A.Malle Company Information
- 4.7.2 K.A.Malle Business Overview
- 4.7.3 K.A.Malle Mebendazole API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 K.A.Malle Mebendazole API Product Portfolio
- 4.7.5 K.A.Malle Recent Developments
- 4.8 Eurosoft Pharma Private Limited
- 4.8.1 Eurosoft Pharma Private Limited Company Information
- 4.8.2 Eurosoft Pharma Private Limited Business Overview
- 4.8.3 Eurosoft Pharma Private Limited Mebendazole API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Eurosoft Pharma Private Limited Mebendazole API Product Portfolio
- 4.8.5 Eurosoft Pharma Private Limited Recent Developments
- 4.9 Enomark Pharma
- 4.9.1 Enomark Pharma Company Information
- 4.9.2 Enomark Pharma Business Overview
- 4.9.3 Enomark Pharma Mebendazole API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Enomark Pharma Mebendazole API Product Portfolio
- 4.9.5 Enomark Pharma Recent Developments
- 4.10 Dolphinpharma
- 4.10.1 Dolphinpharma Company Information
- 4.10.2 Dolphinpharma Business Overview
- 4.10.3 Dolphinpharma Mebendazole API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Dolphinpharma Mebendazole API Product Portfolio
- 4.10.5 Dolphinpharma Recent Developments
- 4.11 Conscientia Industrial Co., Ltd
- 4.11.1 Conscientia Industrial Co., Ltd Company Information
- 4.11.2 Conscientia Industrial Co., Ltd Business Overview
- 4.11.3 Conscientia Industrial Co., Ltd Mebendazole API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Conscientia Industrial Co., Ltd Mebendazole API Product Portfolio
- 4.11.5 Conscientia Industrial Co., Ltd Recent Developments
- 4.12 Cipla
- 4.12.1 Cipla Company Information
- 4.12.2 Cipla Business Overview
- 4.12.3 Cipla Mebendazole API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Cipla Mebendazole API Product Portfolio
- 4.12.5 Cipla Recent Developments
- 4.13 Anant Pharmaceuticals
- 4.13.1 Anant Pharmaceuticals Company Information
- 4.13.2 Anant Pharmaceuticals Business Overview
- 4.13.3 Anant Pharmaceuticals Mebendazole API Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Anant Pharmaceuticals Mebendazole API Product Portfolio
- 4.13.5 Anant Pharmaceuticals Recent Developments
5 Global Mebendazole API Market Scenario by Region
- 5.1 Global Mebendazole API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Mebendazole API Sales by Region: 2021-2032
- 5.2.1 Global Mebendazole API Sales by Region: 2021-2026
- 5.2.2 Global Mebendazole API Sales by Region: 2027-2032
- 5.3 Global Mebendazole API Revenue by Region: 2021-2032
- 5.3.1 Global Mebendazole API Revenue by Region: 2021-2026
- 5.3.2 Global Mebendazole API Revenue by Region: 2027-2032
- 5.4 North America Mebendazole API Market Facts & Figures by Country
- 5.4.1 North America Mebendazole API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Mebendazole API Sales by Country (2021-2032)
- 5.4.3 North America Mebendazole API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Mebendazole API Market Facts & Figures by Country
- 5.5.1 Europe Mebendazole API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Mebendazole API Sales by Country (2021-2032)
- 5.5.3 Europe Mebendazole API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Mebendazole API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Mebendazole API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Mebendazole API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Mebendazole API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Mebendazole API Market Facts & Figures by Country
- 5.7.1 South America Mebendazole API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Mebendazole API Sales by Country (2021-2032)
- 5.7.3 South America Mebendazole API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Mebendazole API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Mebendazole API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Mebendazole API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Mebendazole API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Mebendazole API Sales by Type (2021-2032)
- 6.1.1 Global Mebendazole API Sales by Type (2021-2032) & (t)
- 6.1.2 Global Mebendazole API Sales Market Share by Type (2021-2032)
- 6.2 Global Mebendazole API Revenue by Type (2021-2032)
- 6.2.1 Global Mebendazole API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Mebendazole API Revenue Market Share by Type (2021-2032)
- 6.3 Global Mebendazole API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Mebendazole API Sales by Application (2021-2032)
- 7.1.1 Global Mebendazole API Sales by Application (2021-2032) & (t)
- 7.1.2 Global Mebendazole API Sales Market Share by Application (2021-2032)
- 7.2 Global Mebendazole API Revenue by Application (2021-2032)
- 7.2.1 Global Mebendazole API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Mebendazole API Revenue Market Share by Application (2021-2032)
- 7.3 Global Mebendazole API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Mebendazole API Value Chain Analysis
- 8.1.1 Mebendazole API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Mebendazole API Production Mode & Process
- 8.2 Mebendazole API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Mebendazole API Distributors
- 8.2.3 Mebendazole API Customers
9 Global Mebendazole API Analyzing Market Dynamics
- 9.1 Mebendazole API Industry Trends
- 9.2 Mebendazole API Industry Drivers
- 9.3 Mebendazole API Industry Opportunities and Challenges
- 9.4 Mebendazole API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst